Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence: A Randomized Controlled Trial (BRIDGE AI 3)

NCT07568444 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT07568444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07568444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence: A Randomized Controlled Trial (BRIDGE AI 3)
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Completed
Start date
January 16, 2025
Completion date
February 27, 2025
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, kidney cancers, prostate cancer (adenocarcinoma), testis cancer